开展非商业性国际临床试验:ICR-CTSU的经验
英国ICR-CTSU学术临床试验单元专攻癌症治疗试验的设计、实施与分析,其乳腺、泌尿系分子亚型及其他罕见肿瘤试验组合不断扩大。本文介绍该单元通过稳健的学术与产业合作及适当治理机制,成功实现国际参与并克服法律、伦理与财务体系不协调等挑战的经验。
要点
- 国际试验参与对获取足够患者数以成功实施罕见肿瘤试验日益必要
- 国际法律、伦理与财务体系不协调使国际试验实施具有挑战性
- 通过适当治理机制与强有力合作可成功开展国际学术试验
核心结论
- 开展国际学术试验具有挑战性,但通过适当治理机制与强有力的合作可以且应该实现。
研究设计与样本
- 本文为英国ICR-CTSU学术临床试验单元的经验介绍,该单元专注于癌症治疗试验的设计、实施与分析。
主要发现
- 癌症治疗日益靶向分子亚型且优先开发罕见肿瘤新治疗,对国际试验参与以获取足够患者数的需求不断增长。
- 国际法律、伦理与财务体系缺乏协调使国际试验实施具有挑战性,且国际试验的成本与努力可能被视为 prohibitive,尤其样本量相对较小时。
- 通过稳健的学术与产业合作及适当治理机制,该单元已成功实现国际试验实施。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Academic clinical trials play a fundamental role in the development of new treatments, the repurposing of existing treatments and in addressing areas of unmet clinical need. With cancer treatments increasingly targeted at molecular subtypes, and with priority placed on developing new treatments for rare tumour types, the need for international trial participation to access sufficient patient numbers for successful trial conduct is growing. However, lack of harmonisation of international legal, ethical and financial systems can make this challenging and the cost and effort of conducting trials internationally can be considered prohibitive, particularly where the sample size is comparatively small. METHODS: The Institute of Cancer Research - Clinical Trials and Statistics Unit (ICR-CTSU) is a UK-based academic clinical trials unit that specialises in the design, conduct and analysis of clinical trials of cancer treatments with an expanding portfolio of trials in molecular subtypes of breast and urological cancers and in other rare cancer types. Implementing appropriate mechanisms to enable international participation has therefore been imperative. In this article, we explain how we have approached the challenges involved and describe examples of successful international trial conduct, achieved through robust collaborations with academic and industry partners. CONCLUSION: Conducting academic trials internationally is challenging but can and should be achieved through appropriate governance mechanisms and strong collaborations.
引用
- Fox L, Toms C, Kernaghan S, et al. Conducting non-commercial international clinical trials: the ICR-CTSU experience. Trials. 2017. PMID: 28950887. doi:10.1186/s13063-017-2176-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。